Boussard & Gavaudan Investment Management’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio HAAC Stock Details HAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,000	Closed	-$2K	–	162
2022 Q3	$2K	Hold	200,000	–	–	0.28%	71
2022 Q2	$1.98K	Hold	200,000	–	–	0.36%	57
2022 Q1	$1.97K	Hold	200,000	–	–	0.26%	42
2021 Q4	$1.95M	Hold	200,000	–	–	0.17%	79
2021 Q3	$1.96K	Hold	200,000	–	–	0.17%	75
2021 Q2	$2M	Hold	200,000	–	–	0.19%	38
2021 Q1	$2.03M	Buy	+200,000	New	+$2.37M	0.2%	41

Other funds holding HAAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boussard & Gavaudan Investment Management's HAAC Position: Q4 2022 in Review

Boussard & Gavaudan Investment Management sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 200,000 shares — an estimated $2K sold.

Boussard & Gavaudan Investment Management first reported a position in HAAC in Q1 2021 and held it in 7 quarters. The position peaked at $2.03M in Q1 2021. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

Boussard & Gavaudan Investment Management reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 200,000 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2K.
Boussard & Gavaudan Investment Management first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
Boussard & Gavaudan Investment Management's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $2.03M in Q1 2021.
1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.